341 related articles for article (PubMed ID: 15140644)
1. Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.
Lu XH; Bradley RJ; Dwyer DS
Brain Res; 2004 Jun; 1011(1):58-68. PubMed ID: 15140644
[TBL] [Abstract][Full Text] [Related]
2. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death.
Ruffels J; Griffin M; Dickenson JM
Eur J Pharmacol; 2004 Jan; 483(2-3):163-73. PubMed ID: 14729104
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
4. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes.
Kuwahara K; Saito Y; Kishimoto I; Miyamoto Y; Harada M; Ogawa E; Hamanaka I; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Nakao K
J Mol Cell Cardiol; 2000 Aug; 32(8):1385-94. PubMed ID: 10900165
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of Ca2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells.
Blanc A; Pandey NR; Srivastava AK
Antioxid Redox Signal; 2004 Apr; 6(2):353-66. PubMed ID: 15025937
[TBL] [Abstract][Full Text] [Related]
6. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
Jiang Z; Yu PH
Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
[TBL] [Abstract][Full Text] [Related]
7. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
Chiou WF; Tsai HR; Yang LM; Tsai WJ
Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
[TBL] [Abstract][Full Text] [Related]
8. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.
Gil C; Chaib-Oukadour I; Aguilera J
Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887
[TBL] [Abstract][Full Text] [Related]
9. Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2.
An WL; Pei JJ; Nishimura T; Winblad B; Cowburn RF
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):40-7. PubMed ID: 15857667
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
11. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein.
Cheng G; Yu Z; Zhou D; Mattson MP
Exp Neurol; 2002 Jun; 175(2):407-14. PubMed ID: 12061870
[TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
14. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
Li XA; Bianchi C; Sellke FW
J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
[TBL] [Abstract][Full Text] [Related]
15. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons.
Owada K; Sanjo N; Kobayashi T; Mizusawa H; Muramatsu H; Muramatsu T; Michikawa M
J Neurochem; 1999 Nov; 73(5):2084-92. PubMed ID: 10537068
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways.
Zhu Y; Culmsee C; Klumpp S; Krieglstein J
Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.
Fang X; Yu S; LaPushin R; Lu Y; Furui T; Penn LZ; Stokoe D; Erickson JR; Bast RC; Mills GB
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):135-43. PubMed ID: 11062066
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
Baldanzi G; Filigheddu N; Cutrupi S; Catapano F; Bonissoni S; Fubini A; Malan D; Baj G; Granata R; Broglio F; Papotti M; Surico N; Bussolino F; Isgaard J; Deghenghi R; Sinigaglia F; Prat M; Muccioli G; Ghigo E; Graziani A
J Cell Biol; 2002 Dec; 159(6):1029-37. PubMed ID: 12486113
[TBL] [Abstract][Full Text] [Related]
19. Nicotine exerts neuroprotective effects against β-amyloid-induced neurotoxicity in SH-SY5Y cells through the Erk1/2-p38-JNK-dependent signaling pathway.
Xue MQ; Liu XX; Zhang YL; Gao FG
Int J Mol Med; 2014 Apr; 33(4):925-33. PubMed ID: 24481039
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
